The molecular landscape of ETMR at diagnosis and relapse

Keyphrases

• Molecular Landscape 100%
• Working Diagnosis 100%
• Single nucleotide Variant 100%
• Embryonal Tumor with multilayered Rosettes 100%
• R-loops 100%
• DICER1 66%
• Tumor 33%
• Pediatric 33%
• Aberrations 33%
• Whole Genome Sequencing 33%
• Genomic Landscape 33%
• Germline mutation 33%
• Mutational Signatures 33%
• Primary Tumor 33%
• Tumor Subtype 33%
• MicroRNA 33%
• Effective Treatment 33%
• Treatment Strategy 33%
• Structural Variants 33%
• Embryonal Brain Tumor 33%
• Topoisomerase Inhibitors 33%
• Genomic Instability 33%
• MIR17HG 33%
• PARP Inhibitor (PARPi) 33%
• Chromosomal Instability 33%
• Patient with Tumor 33%
• Cisplatin Treatment 33%
• Somatic Amplification 33%
• Loop Structure 33%
• MiR-17-92 33%

Biochemistry, Genetics and Molecular Biology

• Single-Nucleotide Polymorphism 100%
• Rosette Formation 100%
• R-Loop 100%
• Whole Genome Sequencing 33%
• Germline Mutation 33%
• Cisplatin 33%
• MicroRNA 33%
• Genome Instability 33%
• Chromosome Instability 33%
• Poly ADP Ribose Polymerase 33%
• DNA Topoisomerase 33%
• Topoisomerase 33%
• Somatosensory Amplification 33%
• Genomics 33%